Focused ultrasound ablation for prostatic cancer

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR1900024300

Enrollment

Unknown

Registered

2019-07-05

Start date

2019-07-01

Completion date

Unknown

Last updated

2019-07-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostatic Cancer

Interventions

experiment group:focused ultrasound

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: 1. PCa pathologically confirmed; 2. PCa stage = 70; 4. Safe acoustic path.

Exclusion criteria

Exclusion criteria: 1. active urogenital infection; 2. child bearing desire; 3. contraindication for MRI scan; 4. with other malignant tumors; 5. severe heart, lung, liver, kidney or brain diseases.

Design outcomes

Primary

Measure	Time frame
necrosis;	—

Countries

China

Contacts

Public ContactFeng Yougang

Suining Central Hospital

uroca3@hotmail.com+86 0825 2292601

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026